Literature DB >> 34279819

Low-density lipoprotein receptor-related protein 1 is a CROPs-associated receptor for Clostridioides infection toxin B.

Shengjie Guo1, Yiou Chen1, Jingze Liu1, Xinyi Zhang1, Zhiheng Liu1, Zhuo Zhou2, Wensheng Wei3.   

Abstract

As the leading cause of worldwide hospital-acquired infection, Clostridioides difficile (C. difficile) infection has caused heavy economic and hospitalized burden, while its pathogenesis is not fully understood. Toxin B (TcdB) is one of the major virulent factors of C. difficile. Recently, CSPG4 and FZD2 were reported to be the receptors that mediate TcdB cellular entry. However, genetic ablation of genes encoding these receptors failed to completely block TcdB entry, implicating the existence of alternative receptor(s) for this toxin. Here, by employing the CRISPR-Cas9 screen in CSPG4-deficient HeLa cells, we identified LDL receptor-related protein-1 (LRP1) as a novel receptor for TcdB. Knockout of LRP1 in both CSPG4-deficient HeLa cells and colonic epithelium Caco2 cells conferred cells with increased TcdB resistance, while LRP1 overexpression sensitized cells to TcdB at a low concentration. Co-immunoprecipitation assay showed that LRP1 interacts with full-length TcdB. Moreover, CROPs domain, which is dispensable for TcdB's interaction with CSPG4 and FZD2, is sufficient for binding to LRP1. As such, our study provided evidence for a novel mechanism of TcdB entry and suggested potential therapeutic targets for treating C. difficile infection.
© 2021. Science China Press and Springer-Verlag GmbH Germany, part of Springer Nature.

Entities:  

Keywords:  CRISPR screening; Clostridioides difficile; TcdB; low-density lipoprotein receptor-related protein 1; toxin receptor

Mesh:

Substances:

Year:  2021        PMID: 34279819     DOI: 10.1007/s11427-021-1943-9

Source DB:  PubMed          Journal:  Sci China Life Sci        ISSN: 1674-7305            Impact factor:   6.038


  63 in total

1.  Clostridium difficile toxins may augment bacterial penetration of intestinal epithelium.

Authors:  B A Feltis; A S Kim; K M Kinneberg; D L Lyerly; T D Wilkins; S L Erlandsen; C L Wells
Journal:  Arch Surg       Date:  1999-11

2.  Localization of two epitopes recognized by monoclonal antibody PCG-4 on Clostridium difficile toxin A.

Authors:  S M Frey; T D Wilkins
Journal:  Infect Immun       Date:  1992-06       Impact factor: 3.441

Review 3.  Organizing cell renewal in the intestine: stem cells, signals and combinatorial control.

Authors:  Cécile Crosnier; Despina Stamataki; Julian Lewis
Journal:  Nat Rev Genet       Date:  2006-05       Impact factor: 53.242

4.  Low pH-induced formation of ion channels by clostridium difficile toxin B in target cells.

Authors:  H Barth; G Pfeifer; F Hofmann; E Maier; R Benz; K Aktories
Journal:  J Biol Chem       Date:  2001-01-04       Impact factor: 5.157

5.  A novel toxin homologous to large clostridial cytotoxins found in culture supernatant of Clostridium perfringens type C.

Authors:  Katsuhiko Amimoto; Taichi Noro; Eiji Oishi; Mitsugu Shimizu
Journal:  Microbiology       Date:  2007-04       Impact factor: 2.777

Review 6.  The changing epidemiology of Clostridium difficile infections.

Authors:  J Freeman; M P Bauer; S D Baines; J Corver; W N Fawley; B Goorhuis; E J Kuijper; M H Wilcox
Journal:  Clin Microbiol Rev       Date:  2010-07       Impact factor: 26.132

7.  Clostridium difficile toxin A attenuates Wnt/β-catenin signaling in intestinal epithelial cells.

Authors:  Bruno Bezerra Lima; Bárbara Faria Fonseca; Nathália da Graça Amado; Débora Moreira Lima; Ronaldo Albuquerque Ribeiro; José Garcia Abreu; Gerly Anne de Castro Brito
Journal:  Infect Immun       Date:  2014-04-07       Impact factor: 3.441

8.  Receptor-associated protein is a folding chaperone for low density lipoprotein receptor-related protein.

Authors:  G Bu; S Rennke
Journal:  J Biol Chem       Date:  1996-09-06       Impact factor: 5.157

9.  Clostridium difficile Toxins TcdA and TcdB Cause Colonic Tissue Damage by Distinct Mechanisms.

Authors:  Nicole M Chumbler; Melissa A Farrow; Lynne A Lapierre; Jeffrey L Franklin; D Borden Lacy
Journal:  Infect Immun       Date:  2016-09-19       Impact factor: 3.441

10.  LRP1 expression in colon cancer predicts clinical outcome.

Authors:  Camille Boulagnon-Rombi; Christophe Schneider; Chloé Leandri; Albin Jeanne; Virginie Grybek; Aude Marchal Bressenot; Coralie Barbe; Benjamin Marquet; Saviz Nasri; Christelle Coquelet; Caroline Fichel; Nicole Bouland; Arnaud Bonnomet; Reza Kianmanesh; Anne-Sophie Lebre; Olivier Bouché; Marie-Danièle Diebold; Georges Bellon; Stéphane Dedieu
Journal:  Oncotarget       Date:  2018-01-13
View more
  3 in total

Review 1.  From signal transduction to protein toxins-a narrative review about milestones on the research route of C. difficile toxins.

Authors:  Klaus Aktories
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2022-10-07       Impact factor: 3.195

Review 2.  Peripheral Pathways to Neurovascular Unit Dysfunction, Cognitive Impairment, and Alzheimer's Disease.

Authors:  Amy R Nelson
Journal:  Front Aging Neurosci       Date:  2022-04-18       Impact factor: 5.702

Review 3.  Gene editing and its applications in biomedicine.

Authors:  Guanglei Li; Xiangyang Li; Songkuan Zhuang; Liren Wang; Yifan Zhu; Yangcan Chen; Wen Sun; Zeguang Wu; Zhuo Zhou; Jia Chen; Xingxu Huang; Jin Wang; Dali Li; Wei Li; Haoyi Wang; Wensheng Wei
Journal:  Sci China Life Sci       Date:  2022-02-18       Impact factor: 10.372

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.